Statement by Blue Earth Diagnostics on COVID-19 click here for more information

Our Mission

Developing precision radiopharmaceuticals for patients with cancer.

Learn More

Blue Earth Diagnostics Products


Blue Earth Diagnostics Partnerships

Conferences at Blue Earth Diagnostics

Careers at Blue Earth Diagnostics

Contact Us

Welcome To Blue Earth Diagnostics

Our mission is to transform the clinical management of patients with cancer by developing and delivering innovative molecular imaging technologies to address unmet clinical needs, and reliably inform diagnosis and treatment decisions. Our team is made up of industry leaders and experts in the field of radiopharmaceutical development and commercialisation. Blue Earth Diagnostics is a subsidiary of Bracco Imaging S.p.A., a global leader in diagnostic imaging.

Latest News

View All
Blue Earth Diagnostics Highlights Presentations on Axumin® (Fluciclovine F 18) at Upcoming 2021 ASCO Genitourinary Cancers Symposium (ASCO GU)

BURLINGTON, Mass. and OXFORD, UK, February 8, 2021 – Blue Earth Diagnostics, a Bracco company…

Blue Earth Diagnostics Announces Dosing of Initial Patient in Phase 3 REVELATE Clinical Trial of 18F-Fluciclovine PET Imaging for Detection of Recurrent Brain Metastases

− Clinical utility of Axumin® (fluciclovine F 18) being investigated in expanded areas of cancer…